@article{e92f6606f49547b19535c069cf7f826d,
title = "Anti-tumor necrosis factor therapy in patients with inflammatory bowel disease; comorbidity, not patient age, is a predictor of severe adverse events",
keywords = "Crohn's disease, Ulcerative colitis, Biologicals, Elderly, Co-morbidity, ANTI-TNF THERAPY, ELDERLY-PATIENTS, CROHNS-DISEASE, CHEMOTHERAPY, INFECTIONS, INFLIXIMAB, COLITIS, CANCER, SAFETY, RISK",
author = "Asscher, {Vera E. R.} and {van der Vliet}, Quirine and {van der Aalst}, Karen and {van der Aalst}, Anniek and Brand, {Eelco C.} and {van der Meulen-de Jong}, {Andrea E.} and Bas Oldenburg and Pierik, {Marieke J.} and {van Tuyl}, Bas and Nofel Mahmmod and Maljaars, {P. W. Jeroen} and Fidder, {Herma H.} and {Dutch ICC}",
year = "2020",
month = dec,
doi = "10.1007/s00384-020-03716-6",
language = "English",
volume = "35",
pages = "2331--2338",
journal = "International Journal of Colorectal Disease",
issn = "0179-1958",
publisher = "Springer, Cham",
number = "12",
}